Plasmacytoid dendritic cells and type I interferon in the immunological response against warts
| dc.contributor.author | Saade, Dana | |
| dc.contributor.author | Kurban, Mazen S. | |
| dc.contributor.author | Abbas, Ossama M. | |
| dc.contributor.department | Dermatology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:40:45Z | |
| dc.date.available | 2025-01-24T11:40:45Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Background: Plasmacytoid dendritic cells (pDCs) are the most potent producers of type I interferons (IFNs), and are involved in the pathogenesis of several cutaneous infectious (especially viral), inflammatory/autoimmune and neoplastic entities. Their role in the pathogenesis and regression of human papilloma virus (HPV)-induced skin lesions has not been well studied. Aim: To investigate pDC occurrence and activity in HPV-induced skin lesions, including inflamed and uninflamed warts as well as epidermodysplasia verruciformis (EDV)-associated lesions. Methods: In total 20 inflamed and 20 uninflamed HPV-induced skin lesions (including 7 EDV lesions) were retrieved from our database, and the tissue was immunohistochemically tested for pDC occurrence and activity using anti-BDCA-2 and anti-MxA antibodies, respectively. Results: pDCs were present in all 20 inflamed warts and absent from all 20 uninflamed cases. MxA expression was also diffuse and strong in 75% (15/20) inflamed warts, but not in any of the uninflamed warts. Conclusions: pDCs constitute a central component of the inflammatory host response in inflamed warts, possibly contributing to their regression through production of type I interferons. © 2017 British Association of Dermatologists | |
| dc.identifier.doi | https://doi.org/10.1111/ced.13187 | |
| dc.identifier.eid | 2-s2.0-85032686146 | |
| dc.identifier.pmid | 28736973 | |
| dc.identifier.uri | http://hdl.handle.net/10938/29557 | |
| dc.language.iso | en | |
| dc.publisher | Blackwell Publishing Ltd | |
| dc.relation.ispartof | Clinical and Experimental Dermatology | |
| dc.source | Scopus | |
| dc.subject | Adolescent | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | Aged, 80 and over | |
| dc.subject | Antibodies, monoclonal | |
| dc.subject | Child | |
| dc.subject | Dendritic cells | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Immunohistochemistry | |
| dc.subject | Interferon type i | |
| dc.subject | Male | |
| dc.subject | Middle aged | |
| dc.subject | Myxovirus resistance proteins | |
| dc.subject | Retrospective studies | |
| dc.subject | Staining and labeling | |
| dc.subject | Warts | |
| dc.subject | Young adult | |
| dc.subject | Bdca2 antibody | |
| dc.subject | Immunoglobulin g1 antibody | |
| dc.subject | Interferon | |
| dc.subject | Myxovirus resistance protein a | |
| dc.subject | Myxovirus resistance protein a antibody | |
| dc.subject | Protein antibody | |
| dc.subject | Unclassified drug | |
| dc.subject | Monoclonal antibody | |
| dc.subject | Mx1 protein, human | |
| dc.subject | Myxovirus resistance protein | |
| dc.subject | Article | |
| dc.subject | Clinical article | |
| dc.subject | Cytokine production | |
| dc.subject | Data base | |
| dc.subject | Disease activity | |
| dc.subject | Epidermodysplasia verruciformis | |
| dc.subject | Histopathology | |
| dc.subject | Human | |
| dc.subject | Human cell | |
| dc.subject | Human tissue | |
| dc.subject | Immune response | |
| dc.subject | Inflammation | |
| dc.subject | Plasmacytoid dendritic cell | |
| dc.subject | Priority journal | |
| dc.subject | Protein expression | |
| dc.subject | Skin defect | |
| dc.subject | Tissue section | |
| dc.subject | Verruca vulgaris | |
| dc.subject | Wart virus | |
| dc.subject | Dendritic cell | |
| dc.subject | Immunology | |
| dc.subject | Metabolism | |
| dc.subject | Pathology | |
| dc.subject | Retrospective study | |
| dc.subject | Staining | |
| dc.subject | Very elderly | |
| dc.title | Plasmacytoid dendritic cells and type I interferon in the immunological response against warts | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1